Health In Tech - Class A (HIT) closed at $0.60 on November 4, 2026, up 4.1% from the previous close, on volume of 49,104 shares (30-day average 294,782).
Data as of November 4, 2026.
Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026
PRNewswire (Thu, 29-Oct 6:31 AM ET)
PRNewswire (Tue, 20-Oct 6:31 AM ET)
Health In Tech to Host Annual Meeting of Stockholders
PRNewswire (Fri, 16-Oct 6:30 AM ET)
Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
PRNewswire (Thu, 8-Oct 4:00 PM ET)
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
PRNewswire (Fri, 2-Oct 6:30 AM ET)
PRNewswire (Wed, 30-Sep 4:01 PM ET)
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
PRNewswire (Wed, 9-Sep 6:30 AM ET)
Health In Tech Reports Second Quarter 2026 Financial Results
PRNewswire (Thu, 13-Aug 4:30 PM ET)
Market Chameleon (Wed, 18-Mar 6:29 AM ET)
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
Health In Tech - Class A trades on the NASDAQ stock market under the symbol HIT.
As of November 4, 2026, HIT stock price climbed to $0.60 with 49,104 million shares trading.
HIT has a beta of 0.96, meaning it tends to be less sensitive to market movements. HIT has a correlation of 0.01 to the broad based SPY ETF.
HIT has a market cap of $39.02 million. This is considered a Sub-Micro Cap stock.
Last quarter Health In Tech - Class A reported $8 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $373,964 and missed earnings estimates by -$.01.
The top ETF exchange traded funds that HIT belongs to (by Net Assets): VTI, VXF, IWC.
HIT has underperformed the market in the last year with a return of -79.7%, while the SPY ETF gained +14.7%. In the last 3 month period, HIT fell short of the market, returning -47.6%, while SPY returned -0.3%. However, in the most recent 2 weeks HIT has outperformed the stock market by returning -0.4%, while SPY returned -0.8%.
HIT support price is $.52 and resistance is $.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIT shares will trade within this expected range on the day.
